Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Medical Technology
  • PacBio CEO steps down as Q2 loss widens

PacBio CEO steps down as Q2 loss widens

August 6, 2026Posted inMedical Technology

PacBio has promoted an internal veteran to CEO after Christian Henry stepped down, tasking the new leader with improving sales, expanding the DNA sequencing company’s clinical reach and cutting costs.

Post navigation

Previous Post
us.-launches-disease-tracker-to-improve-monitoring-of-vaccine-preventable-illnesses U.S. Launches Disease Tracker to Improve Monitoring of Vaccine-Preventable Illnesses
Next Post
How Rural Background and Training Shape US Physicians’ Practice Locations how-rural-background-and-training-shape-us-physicians’-practice-locations

Recent Posts

  • AI and Genetic Insights Accelerate Discovery of New Osteoarthritis Treatments
  • Dana-Farber team develops degrader platform, discovers first metabolically activated molecular glue
  • Local Volume Mapper Reveals High-Definition Hyperspectral Maps of Galactic Nurseries
  • Tiny RNA pathway may unlock more powerful stem cell therapies
  • Fruit flies evolved distinct genetic routes to establish heads and tails

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top